52962-52-4 Usage
General Description
4-(1,1-dioxidoisothiazolidin-2-yl)benzoic acid is a chemical compound with the molecular formula C10H9NO4S. It is also known by the trade name Disulfiram, and is used as a medication to help treat chronic alcoholism by causing unpleasant effects such as nausea, vomiting, and flushing when alcohol is consumed. 4-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)BENZOIC ACID works by inhibiting the enzyme aldehyde dehydrogenase, which is involved in the metabolism of alcohol, leading to the accumulation of acetaldehyde in the body. Acetaldehyde buildup results in the unpleasant symptoms, which serves as a deterrent for individuals to continue drinking alcohol. Overall, 4-(1,1-dioxidoisothiazolidin-2-yl)benzoic acid is a pharmacological tool that can be used to support individuals in their efforts to maintain sobriety.
Check Digit Verification of cas no
The CAS Registry Mumber 52962-52-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,9,6 and 2 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 52962-52:
(7*5)+(6*2)+(5*9)+(4*6)+(3*2)+(2*5)+(1*2)=134
134 % 10 = 4
So 52962-52-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H11NO4S/c12-10(13)8-2-4-9(5-3-8)11-6-1-7-16(11,14)15/h2-5H,1,6-7H2,(H,12,13)
52962-52-4Relevant articles and documents
CYCLIC SULFONAMIDE CONTAINING DERIVATIVES AS INHIBITORS OF HEDGEHOG SIGNALING PATHWAY
-
Paragraph 0218, (2014/05/24)
The invention relates generally to the creation and use of cyclic sulfonamide containing derivatives to inhibit the hedgehog signaling pathway and to the use of those compounds for the treatment of hyperproliferative diseases and angiogenesis mediated diseases.
SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa
Qiao, Jennifer X.,Chang, Chong-Hwan,Cheney, Daniel L.,Morin, Paul E.,Wang, Gren Z.,King, Sarah R.,Wang, Tammy C.,Rendina, Alan R.,Luettgen, Joseph M.,Knabb, Robert M.,Wexler, Ruth R.,Lam, Patrick Y.S.
, p. 4419 - 4427 (2008/02/10)
In the search of Factor Xa (FXa) inhibitors structurally different from the pyrazole-based series, we identified a viable series of enantiopure cis-(1R,2S)-cycloalkyldiamine derivatives as potent and selective inhibitors of FXa. Among them, cyclohexyldiam